Tomorrow, 16th September 2020 LABION – Fondazione Don Gnocchi has the pleasure to chair two tematic sessions together with University of Modena e Reggio Emilia
Register and follow remotely our thematic session and all the interesting talk of the national meeting place for the wide and multidisciplinary community involved in the development of nanotechnologies and their integration with other key enabling technologies (KETs), in all application fields.
https://www.nanoinnovation2020.eu/home/
Here below the program of the Thematic Symposia:
14:00 – 15:30 Innovation in Nanotherapeutics and Nanodiagnostics
Co-organized with University of Modena and Reggio Emilia and IRCCS Fondazione Don Gnocchi
Chair: Giovanni TOSI, Nanomedicine Platform of University of Modena and Reggio Emilia
The session, co-chaired by Dr. Marzia Bedoni (Don Gnocchi Foundation) and Prof. Giovanni Tosi (University of Modena and Reggio Emilia), will deal different innovative aspects of nanomedicines and their application in pathologies with special focus on Brain Disorders, Regenerative Medicine, Cancer & Glioblastoma.
Francesca RE
University of Bicocca, Milan
b-Amyloid-induced oxidative stress boosts CeO2 nanoparticles uptake by changing brain endothelium microvilli pattern
Raymond SCHIFFELERS
UMC Utrecht, Holland
Synthetic lipid nanoparticles or extracellular vesicles for RNA delivery
Frank BOURY
University of Angers, France
Bioimplant for the trapping of glioblastoma cells
Jason DUSKEY
University of Modena and Reggio Emilia
Brain Targeted Nanomedicine: More Than Just Crossing the BBB
16:00 – 17:30 Fostering Nanomedicine into Industrial and Clinic Setting
Co-organized with University of Modena and Reggio Emilia and IRCCS Fondazione Don Gnocchi
Chair: Marzia BEDONI, Laboratory of Nanomedicine and Clinical Biophotonics (LABION), IRCCS Fondazione Don Gnocchi
The session, co-chaired by Dr. Marzia Bedoni (Don Gnocchi Foundation) and Prof. Giovanni Tosi (University of Modena and Reggio Emilia), will deal different aspects of nanomedicines in terms of development of nanomedicines in both industrial and clinical setting. Special Focus will be dedicated to Clinical Translation, Characterization, Biosafety, Upscaling.
Maria DE LA FUENTE
Health Research Institute of Santiago de Compostela, Spain
Personalized nanomedicine for improved anticancer therapeutics
Adriele PRINA-MELLO
Trinity College Dublin, Ireland
Measuring particle concentration of multimodal materials with orthogonal techniques. Stepping up to the characterisaton complexity
Davide MALAGOLI
University of Modena and Reggio Emilia, Italy
The apple snail Pomacea canaliculata: a new and alternative animal model for testing innovative nanomedicines
Robert PROUD’HOMME
Princeton University, USA
Nanomedicine: from high tech to global health
